Testing effectiveness (Phase 2)Looking for participantsNCT06874010
What this trial is testing
A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia
Who this might be right for
Friedreich Ataxia
Design Therapeutics, Inc. 20